Twist Bioscience Corporation

Financials

Cash from operating activities -142.25 M-112.24 M-124.39 M-142.47 M-64.09 M-47.63 M -51.01 M Cash from investing activities -114.65 M156.16 M-232.93 M50.61 M-3.07 M-24.76 M -33.16 M Cash from financing activities 303.73 M329.18 M270.53 M911 K6.89 M28.54 M 10.89 M Free cash flow -152.12 M-157.71 M-226.24 M-170.25 M-69.17 M-75.63 M -86.72 M

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

News

ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025 - Advanced Micro Devices (NASDAQ:AMD), Robinhood Markets (NASDAQ:HOOD), Palantir Technologies (NASDAQ:PLTR), Trade Desk (NASDAQ:TTD)

TWST

Financials